Company Overview of Elcelyx Therapeutics, Inc.
Key Executives for Elcelyx Therapeutics, Inc.
|Alain D. Baron M.D.||12 Relationships||Chief Executive Officer, President, Member of Management Board and Director||62|
|Martin R. Brown||No Relationships||Senior Vice President of Finance & Operations||69|
|Mark Fineman Ph.D.||No Relationships||Senior Vice President of R&D||--|
|Karen Basbaum||No Relationships||Vice President of Business Development||--|
|Thomas Bicsak Ph.D.||No Relationships||Vice President of Regulatory Affairs & Quality Assurance||--|
Elcelyx Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Ralph E. Christoffersen Ph.D., J.D.||64 Relationships||Galleon Pharmaceuticals, Inc.||78|
|Alain D. Baron M.D.||12 Relationships||Elcelyx Therapeutics, Inc.||62|
|James W. Glasheen Ph.D.||28 Relationships||Technology Partners||49|
|Ginger L. Graham||122 Relationships||Genomic Health, Inc.||60|
|Richard Jon Barry||16 Relationships||Sarepta Therapeutics, Inc.||57|
Elcelyx Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.